Skip to content
Search

Latest Stories

TECHNOLOGY: Keeping ahead of technology

Tracey Robertson explains how an extensive and imaginative use of technology can help community pharmacy reach its true potential…

Community pharmacy first recognised the value in using technology to automate and streamline processes back in the ’80s, when machine generated labels were first required. Since then, we have seen many new electronic solutions to stream line work flow and optimize care, such as the arrival of electronic prescribing and integrated care.


Technology is one of the most adaptive elements of a pharmacy and the single biggest enabler when it comes to implementing change. Technology solutions offer pharmacists the ability to support and improve patient pathways, including new ways to interact with healthcare professionals, such as remote consultations, or checking medication adherence through compliance tools.

Covid-19 impact

Coronavirus has acted as a catalyst for digital transformation across a variety of sectors in order for services to continue as normal, including retail, logistics and healthcare. It has typically been more challenging to increase the uptake of technology in healthcare settings, including community pharmacy environments, as traditional models of delivering patient care remain at the forefront.

However, the pandemic has rapidly changed the use of innovation for the better. For example, more than 85 per cent of primary care prescriptions in England are now processed electronically, after a rise in use of the service during the pandemic.

Since March, pharmaceutical companies have had to adapt to the shift in global health priorities. With the NHS urgently trying to relieve the pressure on GPs and hospitals duringCovid-19, there is no doubt that pharmacies will experience a rise in the number of NHS services they have the opportunity to deliver over the coming years.

However, to do this, integrated systems that allow pharmacists to deliver end-to-end services to patients with fully streamlined and intuitive workflows that share data between all systems are necessary.

page 4 photo One size won’t fit all, but pharmacists need to be aware of their options

Connected systems

The importance of fast, accurate and trusted communication came into sharp focus during the height ofCovid-19.Fromsharing patient information to making rapid decisions, the ability to quickly share concise, relevant and consistent information across all departments has never been more essential to the running of pharmacy.

Digital platforms can enable amore integrated and connected care system which offers a holistic view for medical professionals and patient services. Health care professionals can be linked to one another and access the information they need, from pharmacist to GP, which allows different organizations to work together for better and more joined up patient care.

By having a connected healthcare system, this proactive approach maximises healthcare resources and provides flexible opportunities for communication with clinicians and patients self-managing their care. In turn, patients are put at the centre of their care.

Additionally, by utilising these digital platforms, a vast amount of data is harnessed, which can be used to analyse outcomes or offer new insights into medications and patient experiences. This information can then be used to benefit the health of the broader population.

As the pharmacy profession continues to evolve, keeping ahead of technology changes is vitally important. Technology can be used to streamline traditional core operations like the assembly and labelling of medicines, which will enable pharmacists to engage with new, developing core activities, primarily interacting with and advising patients. One size of technology will definitely not fit all, but pharmacists need to be aware of their options.

However, pharmacists must have an open-minded approach with some flexibility and “outside of the box” thinking when considering new solutions. Embracing technology can challenge current thinking, such as the introduction of barcode scanning into the workflow following the Falsified Medicines Directive.

Pharmacies can be fixed on not wanting to change their current workflow, and in doing so, may fail to recognise the benefits and wider efficiencies that other approaches can deliver.

Right technology

There are many reasons for pharmacies to invest in new technology, including reducing costs, increasing workflow efficiencies and automating processes. The key in selecting the right technology is to focus on the value of the investment, considering the anticipated savings, impact on productivity and qualitative benefits.

The value of an automated solution can help save valuable staff time, improve repeat prescription management, build patient loyalty and ultimately improve medication adherence, in turn boosting patient wellbeing.

Ready for innovation

It’s essential to have the correct infrastructure in place in order for systems to work effectively and seamlessly. Key components of this include connectivity, hardware and service.

For a pharmacy, the link with GP surgeries is key, and the quality and reliability of connectivity to the NHS spine is vital to business continuity. Additionally, to have a smooth running PMR system, it’s important to pick the right hardware, as well as finding out what is included such as who is responsible for maintenance, support and fixing any problems if they were to arise.

Pharmacies need a support service that is just as fast and reliable as the rest of their IT solution so that they can deliver a consistently good customer experience. Busy pharmacy environments will be ne f it significantly by being able to put their resources and time into more urgent tasks, rather than having to deal with any technical issues.

Digitising pharmacy environments has an enormous potential to improve patient care, increase safety and efficiency, as well as reduce staff time and costs. Pharmacists are the front door to the NHS in the community, which is why it is vital that they continue to embrace digital solutions and reap the benefits.

It’s important that postCovid-19, the momentum for technology innovation is not slowed down, but continues to accelerate now and into the future.

Tracey Robertson is product director at Cegedim Healthcare Solutions.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less